🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Beijing
Clinical trial register · China

Clinical Trials in Beijing, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 139 Shenzhen 10 Fuzhou 4 Xi'an 4 Chongqing 4
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Peking Union Medical College Hospital276 Beijing Tiantan Hospital214 Cancer Institute and Hospital, Chinese Academy of Medical Sciences197 AstraZeneca183 Peking University People's Hospital158 Clear sponsor filter
Site location
Beijing139 Shenzhen10 Fuzhou4 Xi'an4 Chongqing4
All 47 locations
Target enrolment
to

Trials with a site in Beijing

139 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
SABR Combined With Targeted Therapy and Anti-PD-1 for Recurrent or Metastatic Renal Cancer
NCT06583070Radiation Therapy, Metastatic Renal Cancer, Recurrent Renal Cell Cancer
Peking University First Hospital
Observational
300
Beijing
2024-02-02
Recruiting
Different Dose Esketamine and Dexmedetomidine for Supplemental Analgesia and Longterm Outcomes
NCT06087510Scoliosis Correction, Postoperative Analgesia, Esketamine, Dexmedetomidine
DrugEsketamine
Peking University First Hospital
Phase 4
312
Beijing
2024-01-24
Recruiting
Establishment and Promotion of an AI-Based Early Warning System for Prostate and Bladder Cancer Screening in the Male Community Population of Beijing
NCT07319923Prostate Cancer, Community-based Screening
Peking University First Hospital
Observational
3,000
Beijing
2024-01-01
Recruiting
The Development and Validation of MRI-AI-based Predictive Models for csPCa
NCT06842264Prostate Cancer
Peking University First Hospital
Observational
3,000
Beijing
2024-01-01
Active, closed
Different Dose Esketamine and Dexmedetomidine Combination for Supplemental Analgesia After Scoliosis Correction Surgery
NCT06062550Scoliosis Correction, Esketamine, Dexmedetomidine, Postoperative Analgesia
DrugEsketamine
Peking University First Hospital
Phase 4
312
Beijing
2023-10-24
Not yet open
Efficacy and Safety of Nab-paclitaxel-Lenvatinib-Pembrolizumab as Second-line Treatment in Advanced NSCLC Patients
NCT06028633Advanced Non-squamous Non-small-cell Lung Cancer, Recurrent Non-Squamous Non-Small Cell Lung Cancer, Metastatic Non-squamous Non Small Cell Lung Cancer
Peking University First Hospital
Phase 2
28
Beijing
2023-10
Recruiting
Perioperative Dexmedetomidine and Long-term Survival After Cancer Surgery
NCT06030804Elderly, Cancer Surgery, Dexmedetomidine, Long-Term Survivors
DrugDexmedetomidine
Peking University First Hospital
Not applicable
4,532
Hefei, Beijing, Chongqing, Fuzhou, Jinjiang, Guangzhou, Shenzhen, Nanning
2023-09-12
Active, closed
Effect of Low-dose Esketamine on Maternal Depression at 3 Years After Childbirth
NCT05698394Prenatal Depression, Ketamine, Postpartum Depression
DrugEsketamine
Peking University First Hospital
Phase 4
364
Changsha, Nanjing, Hangzhou, Beijing
2023-09-09
Recruiting
Digital Cognitive Behavioral Therapy for Insomnia for Chronic Insomnia in Breast Cancer Survivors
NCT05813392Chronic Insomnia
Peking University First Hospital
Not applicable
264
Beijing
2023-08-29
Recruiting
A Study on the Impact of Bivalirudin Usage During PCI for High-risk Plaques on Post-PCI Coronary Microcirculation.
NCT05984537Coronary Microvascular Dysfunction
Peking University First Hospital
Phase 4
70
Beijing
2023-07-01
Recruiting
68Ga-P3 PET/CT Imaging in Prostate
NCT05940259Neoplasms
Peking University First Hospital
Not applicable
30
Beijing
2023-05-29
Recruiting
Impact of Erector Spinae Plane Block on Chronic Postsurgical Pain in Breast Cancer Patients
NCT05494502Breast Neoplasms, Mastectomy, Nerve Block, Dexmedetomidine
Peking University First Hospital
Not applicable
1,206
Beijing
2023-05-23
Recruiting
68Ga-P3 PET/CT Imaging in Malignancy
NCT05887687Neoplasms
Peking University First Hospital
Not applicable
350
Beijing
2023-05-20
Recruiting
A Clinical Study of Fundus OCTA for the Identification of CMD
NCT05743140Coronary Microvascular Disease
Peking University First Hospital
Observational
400
Beijing
2023-03-01
Not yet open
Imapct of bioMarkers on Pharmacodynamics and Bleeding Risk of Direct Oral AntiCoagulants and Ticagrelor Study II
NCT05764356Novel Oral Anticoagulants, NOACs, Rivaroxaban, Apixaban
Peking University First Hospital
Observational
2,000
Hefei, Beijing, Chongqing, Zhengzhou, Shanghai
2023-03
Recruiting
Development and Validation of a Real-time Prediction Model for Acute Kidney Injury in Hospitalized Patients
NCT06597838Prediction Model
Peking University First Hospital
Observational
161,876
Beijing
2023-02-28
Active, closed
Mechanism and Immune Function Analysis of SARS-CoV-2 Infection in Hematologic Tumors
NCT05683353SARS-CoV-2 Infection, Hematologic Malignancy
Peking University First Hospital
Observational
60
Beijing
2022-12-14
Recruiting
68Ga-N188 PET/CT Imaging in Malignancy
NCT05593107Neoplasms
Peking University First Hospital
Not applicable
203
Beijing
2022-08-12
Recruiting
TreAtments and outComes in paTients With prImary CutAneous Lymphoma
NCT05518851Primary Cutaneous Lymphoma
Peking University First Hospital
Observational
3,000
Beijing, Guandong, Nanjing, Jinan
2022-08-01
Recruiting
General Anesthetics-related Changes in Prefrontal EEG During Pediatric Surgical Anesthesia
NCT05210764General Anesthetic, Electroencephalogram
DrugsS-ketamine·Sevoflurane·Propofol
Peking University First Hospital
Observational
366
Beijing
2022-06-01
Recruiting
Postoperative Adjuvant Immunotherapy Combined with Radiotherapy Versus Surgery Alone in Locally Advanced UTUC
NCT06598761Ureter Cancer, Renal Pelvic Carcinoma, Advanced Urothelial Carcinoma
Peking University First Hospital
Observational
60
Beijing
2022-01-01
Recruiting
Adjuvant Radioimmunotherapy Compared With Adjuvant Chemotherapy for UTUC
NCT06120374Urothelial Carcinoma
Peking University First Hospital
Observational
178
Beijing
2022-01-01
Recruiting
Radiotherapy Combined with Systemic Therapy Versus Systemic Therapy for Oligometastatic UTUCs
NCT06652022Oligometastatic Disease, Ureter Cancer, Renal Pelvic Carcinoma
Peking University First Hospital
Not applicable
102
Beijing
2022-01-01
Recruiting
Radical Radiotherapy Versus Radical Surgery for UTUC
NCT06652009Renal Pelvis Cancer
Peking University First Hospital
Observational
60
Beijing
2022-01-01
Recruiting
Pembrolizumab Monotherapy Following Tri-modality Treatment for Selected Patients With Muscle-invasive Bladder Cancer
NCT05072600Bladder Cancer, Bladder Neoplasms, Bladder Tumors, Urinary Bladder Cancer
Peking University First Hospital
Phase 2
54
Beijing
2021-12-07
Recruiting
Multicomponent Prehabilitation and Outcomes in Elderly Patients With Frailty
NCT04715581Old Age; Debility, Digestive Cancer, Surgery, Preoperative Rehabilitation
Peking University First Hospital
Not applicable
540
Beijing
2021-11-25
Recruiting
China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project
NCT05316805Atopic Dermatitis Eczema, Prurigo Nodularis
Peking University First Hospital
Observational
100,000
Beijing
2021-08-31
Recruiting
A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH
NCT05283993Multiple Myeloma, Amyloidosis, Cryoglobulinemia, Castleman's Disease
Peking University First Hospital
Observational
2,000
Beijing
2021-07-01
Recruiting
Protocol-based Management and Perioperative Outcomes in Patients With Chronic Antithrombotic Therapy
NCT04852406Antithrombotic Therapy, Perioperative Care, Perioperative Outcomes
Peking University First Hospital
Not applicable
526
Beijing
2021-04-21
Recruiting
Impact of Remimazolam on Prognosis After Bladder Cancer Surgery
NCT04532606Benzodiazepines, Bladder Cancer, Delirium, Surgery
DrugsRemimazolam·Propofol
Peking University First Hospital
Phase 4
1,128
Beijing, Beijin, Guiyang, Nanjing, Shanghai
2021-02-05
Active, closed
Dexmedetomidine and Outcomes of Elderly Admitted to ICU After Surgery
NCT04204798Elderly, Surgery, Intensive Care Unit, Dexmedetomidine
DrugDexmedetomidine
Peking University First Hospital
Not applicable
1,410
Beijing
2020-08-28
Recruiting
Intraoperative Blood Pressure Management and Dexamethasone in Lung Cancer Surgery
NCT04209218Lung Cancer, Surgery, Blood Pressure Management, Dexamethasone
DrugDexamethasone
Peking University First Hospital
Not applicable
1,988
Beijing
2020-04-07
Active, closed
Perioperative Epidural Block and Dexamethasone in Pancreatic Cancer Surgery
NCT04025840Pancreatic Cancer, Surgery, Epidural Block, Dexamethasone
DrugDexamethasone
Peking University First Hospital
Phase 4
260
Beijing
2019-09-11
Recruiting
Adjuvant Chemotherapy for High Malignant Prostate Cancer
NCT06864533Prostate Cancer, Radiation Therapy, Chemotherapy, Gleason Score
DrugDocetaxel
Peking University First Hospital
Observational
315
Beijing, Shenzhen, Baoding
2019-09-01
Recruiting
Aspirin 50 mg vs. 100 mg in Elderly Cardiovascular Disease Patients
NCT07542860Atherosclerotic Cardiovascular Disease (ASCVD), Secondary Prevention, Cardiovascular Diseases
Peking University First Hospital
Observational
5,448
Beijing
2019-04-10
Recruiting
SABR Combined with Axitinib and Toripalimab in Recurrent or Metastatic RCC
NCT06889649Radiation Therapy, Targeted Therapy, Immunotherapy, Renal Cancer Metastatic
Peking University First Hospital
Phase 2
30
Beijing
2019-01-01
Recruiting
Targeted Blood-pressure Management and Acute Kidney Injury After Coronary Artery Bypass Surgery
NCT03629418Coronary Artery Bypass, Off-Pump, Intraoperative Hypotension, Acute Kidney Injury, Preventive Medicine
DrugNorepinephrine
Peking University First Hospital
Not applicable
612
Beijing
2018-08-14
Active, closed
Dexmedetomidine Supplemented Analgesia and Long-term Survival After Cancer Surgery
NCT03012971Elderly, Surgery, Analgesia, Dexmedetomidine
Peking University First Hospital
Not applicable
1,500
Beijing, Chongqing, Guiyang, Baoding, Changsha, Xi'an, Qingdao, Taiyuan
2017-01-06
Active, closed
Chinese Cohort Study of Chronic Kidney Disease
NCT03041987Renal Insufficiency, Chronic
Peking University First Hospital
Observational
5,000
Beijing
2012-01-01
Rows per page Showing 101–139 of 139
Previous 1 2
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 27 September 2026. https://priyalifescience.com/clinical-trials-china/city/beijing?page=2

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 139 of those studies with a site in Beijing that also match the filters currently applied.

How many clinical trials are recruiting in Beijing?

91 of the 139 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 28 have not yet opened recruitment, 13 are active but closed to new participants, and 7 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.